Astria Therapeutics

company

About

Astria Therapeutics discovers and develops innovative drugs for treating inflammatory conditions.

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$100M
Industries
Biopharma,Biotechnology,Health Care,Medical
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active
Stock Symbol
nasdaq:CATB
Legal Name
Astria Therapeutics, Inc.
Also Known As
Catabasis Pharmaceuticals

Catabasis Pharmaceuticals is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. Their platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of a novel mechanism of action therapies to safely and effectively treat inflammatory diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
15
$469.53M
Astria Therapeutics has raised a total of $469.53M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 15, 2022 Post-IPO Equity $100M Detail
Feb 8, 2021 Post-IPO Equity $110.01M Detail
Jan 29, 2020 Post-IPO Equity $26.50M Detail
Jun 22, 2018 Post-IPO Equity $42M Detail
Sep 28, 2016 Post-IPO Equity $11.50M Detail

Investments

Number of Investments
Number of Lead Investments
4
1
Astria Therapeutics has made 4 investments. Their most recent investment was on May 5, 2020, when Dazzle Rocks raised $6.80M.
Date Company Name
Round Money Raised Industry Lead Investor
May 5, 2020 Dazzle Rocks
Series A $6.80M MMO Games
Sep 3, 2019 Dreamdata
Pre-seed $535K Analytics
Jul 18, 2018 FRVR
Seed $3M Android
Oct 7, 2017 Lix Technologies
Series A $5.40M E-Learning Yes

Investors

Number of Lead Investors
Number of Investors
8
5
Astria Therapeutics is funded by 5 investors. Lightstone Ventures and Advanced Technology Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Lightstone Ventures Yes Series B
Advanced Technology Ventures Series B
Clarus Ventures Series B
MedImmune Ventures Series B
SV Health Investors Series B

Employee Profiles

Number of Employee Profiles
5
Astria Therapeutics has 5 current employee profiles, including Board member Jean George
Board member
Executive
Board member
Executive

Acquisition

Astria Therapeutics has acquired 1 organizations. Their most recent acquisition was Quellis Biosciences on Jan 29, 2021. They acquired Quellis Biosciences for 0.

Date Company Name
Industry Acquisition Type Price
Biotechnology acquisition Detail